Please ask us questions!
787-900-5661
info@prmedcenter.com
Please let us know you!

Research Studies

We are continuous working with new lines of treatment that have become the new hope for many patients.

AllBreast2Hepatocellular1Myeloma1NSCLC3RRMM1

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Randomized Open label Population: Locally advanced Not amenable to surgery / Radio the OR Metastatic Disease ER (+) &…

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Window Study Population: Localized & operable: Stage IIStage III Newly diagnosed, Pre-operative post-menopausal ER(+) & HER-2 (-)

Hepatocellular

Type of Cancer: Hepatocellular Sponsor: Merck Phase / Design: Phase 3 Randomized Double-blind Population: Incurable Nonmetastatic HCC No macrovascular invasion. Not amenable to transplant All lesions amenable to TACE in…

Myeloma

Type of Cancer: Relapsed and/or refractory multiple myeloma (RRMM) Sponsor: Sanofi Phase / Design: Observational Population:

NSCLC

Type of Cancer: NSCLC Sponsor: Merck Phase / Design: Phase 3 Randomized Open label (Rescue site) Population: Metastatic EGFR mutation (-)  

NSCLC

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Open label Population: Locally advanced: Stage IIIA, IIIB, or IIIC Unresectable Amenable to Chemoradiotherapy Naïve EGFR mutation (-)

NSCLC

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Double-blind Population: Resectable Stage II-IIIB Naïve EGFR mutation (-)
Menu